News

UK Biobank has launched a new Global Researcher Access Fund that covers application costs of approved researchers at institutes from less wealthy countries.

Researchers have a new place to discuss the use of UK Biobank data, learn about the tools and methods needed to analyse our large datasets, and share their advice for like-minded researchers around the world.

This week UK Biobank welcomed the Secretary of State for Science, Innovation and Technology, Michelle Donelan, to officially mark the future site of UK Biobank’s new centre

A new paper was published this week in the journal Science Translational Medicine, titled ‘Prospective study design and data analysis in UK Biobank’.

In a momentous landmark for medical research, UK Biobank has today unveiled incredible new data from whole genome sequencing of its half a million participants.

Professor Rory Collins, Principal Investigator and Chief Executive of UK Biobank responds to claims about inappropriate access to UK Biobank data.

Former CEO and Chairman of Google Eric Schmidt and Citadel CEO Ken Griffin donate over £16 million – matched by Government – for consortium to scale up UK Biobank’s wealth of health data

First-of-its-kind dataset – based on samples from over 54,000 UK Biobank volunteer participants – lays the foundation for future discovery of new drug targets.

UK Biobank participants have been meeting at focus groups all over the UK to discuss their views on two important issues.

UK Biobank, the world’s most significant source of data and biological samples for health research, is set to receive £127.6m to fund a move to a larger, faster, and more efficient, purpose-built facility at Bruntwood SciTech’s Manchester Science Park.